Atlas Trials

Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Clinical trial NCT00006462 · COMPLETED

Trial details

NCT number
NCT00006462
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2001-04-01
Primary completion
2003-08-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.